Literature DB >> 20829372

Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL.

Robin Jeannet1, Jérôme Mastio, Alejandra Macias-Garcia, Attila Oravecz, Todd Ashworth, Anne-Solen Geimer Le Lay, Bernard Jost, Stéphanie Le Gras, Jacques Ghysdael, Thomas Gridley, Tasuku Honjo, Freddy Radtke, Jon C Aster, Susan Chan, Philippe Kastner.   

Abstract

The Notch pathway is frequently activated in T-cell acute lymphoblastic leukemias (T-ALLs). Of the Notch receptors, Notch1 is a recurrent target of gain-of-function mutations and Notch3 is expressed in all T-ALLs, but it is currently unclear how these receptors contribute to T-cell transformation in vivo. We investigated the role of Notch1 and Notch3 in T-ALL progression by a genetic approach, in mice bearing a knockdown mutation in the Ikaros gene that spontaneously develop Notch-dependent T-ALL. While deletion of Notch3 has little effect, T cell-specific deletion of floxed Notch1 promoter/exon 1 sequences significantly accelerates leukemogenesis. Notch1-deleted tumors lack surface Notch1 but express γ-secretase-cleaved intracellular Notch1 proteins. In addition, these tumors accumulate high levels of truncated Notch1 transcripts that are caused by aberrant transcription from cryptic initiation sites in the 3' part of the gene. Deletion of the floxed sequences directly reprograms the Notch1 locus to begin transcription from these 3' promoters and is accompanied by an epigenetic reorganization of the Notch1 locus that is consistent with transcriptional activation. Further, spontaneous deletion of 5' Notch1 sequences occurs in approximately 75% of Ikaros-deficient T-ALLs. These results reveal a novel mechanism for the oncogenic activation of the Notch1 gene after deletion of its main promoter.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20829372      PMCID: PMC3100247          DOI: 10.1182/blood-2010-05-286658

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  40 in total

1.  Direct induction of T lymphocyte-specific gene expression by the mammalian Notch signaling pathway.

Authors:  Boris Reizis; Philip Leder
Journal:  Genes Dev       Date:  2002-02-01       Impact factor: 11.361

2.  Eaf3 chromodomain interaction with methylated H3-K36 links histone deacetylation to Pol II elongation.

Authors:  Amita A Joshi; Kevin Struhl
Journal:  Mol Cell       Date:  2005-12-22       Impact factor: 17.970

3.  Two distinct Notch1 mutant alleles are involved in the induction of T-cell leukemia in c-myc transgenic mice.

Authors:  C D Hoemann; N Beaulieu; L Girard; N Rebai; P Jolicoeur
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

4.  Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision.

Authors:  Hua Han; Kenji Tanigaki; Norio Yamamoto; Kazuki Kuroda; Momoko Yoshimoto; Tatsutoshi Nakahata; Koichi Ikuta; Tasuku Honjo
Journal:  Int Immunol       Date:  2002-06       Impact factor: 4.823

5.  Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8T cell development.

Authors:  A Wolfer; T Bakker; A Wilson; M Nicolas; V Ioannidis; D R Littman; P P Lee; C B Wilson; W Held; H R MacDonald; F Radtke
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

6.  TEL-JAK2 transgenic mice develop T-cell leukemia.

Authors:  C Carron; F Cormier; A Janin; V Lacronique; M Giovannini; M T Daniel; O Bernard; J Ghysdael
Journal:  Blood       Date:  2000-06-15       Impact factor: 22.113

7.  Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis.

Authors:  Diana Bellavia; Antonio F Campese; Saula Checquolo; Anna Balestri; Andrea Biondi; Giovanni Cazzaniga; Urban Lendahl; Hans J Fehling; Adrian C Hayday; Luigi Frati; Harald von Boehmer; Alberto Gulino; Isabella Screpanti
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

8.  Inactivation of Notch1 impairs VDJbeta rearrangement and allows pre-TCR-independent survival of early alpha beta Lineage Thymocytes.

Authors:  Anita Wolfer; Anne Wilson; Mohamed Nemir; H Robson MacDonald; Freddy Radtke
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

9.  Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes.

Authors:  M L Deftos; E Huang; E W Ojala; K A Forbush; M J Bevan
Journal:  Immunity       Date:  2000-07       Impact factor: 31.745

10.  Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice.

Authors:  D Bellavia; A F Campese; E Alesse; A Vacca; M P Felli; A Balestri; A Stoppacciaro; C Tiveron; L Tatangelo; M Giovarelli; C Gaetano; L Ruco; E S Hoffman; A C Hayday; U Lendahl; L Frati; A Gulino; I Screpanti
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

View more
  39 in total

1.  An activating intragenic deletion in NOTCH1 in human T-ALL.

Authors:  J Erika Haydu; Kim De Keersmaecker; Mary Kaye Duff; Elisabeth Paietta; Janis Racevskis; Peter H Wiernik; Jacob M Rowe; Adolfo Ferrando
Journal:  Blood       Date:  2012-04-17       Impact factor: 22.113

2.  Deletion-based mechanisms of Notch1 activation in T-ALL: key roles for RAG recombinase and a conserved internal translational start site in Notch1.

Authors:  Todd D Ashworth; Warren S Pear; Mark Y Chiang; Stephen C Blacklow; Jérôme Mastio; Lanwei Xu; Michelle Kelliher; Philippe Kastner; Susan Chan; Jon C Aster
Journal:  Blood       Date:  2010-09-17       Impact factor: 22.113

3.  Enforced expression of Lin28b leads to impaired T-cell development, release of inflammatory cytokines, and peripheral T-cell lymphoma.

Authors:  Sarah H Beachy; Masahiro Onozawa; Yang Jo Chung; Chris Slape; Sven Bilke; Princy Francis; Marbin Pineda; Robert L Walker; Paul Meltzer; Peter D Aplan
Journal:  Blood       Date:  2012-06-21       Impact factor: 22.113

Review 4.  The molecular pathogenesis of chronic lymphocytic leukaemia.

Authors:  Giulia Fabbri; Riccardo Dalla-Favera
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

Review 5.  Critical roles of NOTCH1 in acute T-cell lymphoblastic leukemia.

Authors:  Hudan Liu; Mark Y Chiang; Warren S Pear
Journal:  Int J Hematol       Date:  2011-08-05       Impact factor: 2.490

6.  Cutting Edge: Codeletion of the Ras GTPase-Activating Proteins (RasGAPs) Neurofibromin 1 and p120 RasGAP in T Cells Results in the Development of T Cell Acute Lymphoblastic Leukemia.

Authors:  Beth A Lubeck; Philip E Lapinski; Jennifer A Oliver; Olga Ksionda; Luis F Parada; Yuan Zhu; Ivan Maillard; Mark Chiang; Jeroen Roose; Philip D King
Journal:  J Immunol       Date:  2015-05-22       Impact factor: 5.422

7.  Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.

Authors:  Jessica Tatarek; Kathleen Cullion; Todd Ashworth; Rachel Gerstein; Jon C Aster; Michelle A Kelliher
Journal:  Blood       Date:  2011-06-13       Impact factor: 22.113

8.  High mobility group A1 protein acts as a new target of Notch1 signaling and regulates cell proliferation in T leukemia cells.

Authors:  Yang Xi; Yu-Sang Li; He-Bin Tang
Journal:  Mol Cell Biochem       Date:  2012-11-16       Impact factor: 3.396

9.  Ikaros inhibits megakaryopoiesis through functional interaction with GATA-1 and NOTCH signaling.

Authors:  Sébastien Malinge; Clarisse Thiollier; Timothy M Chlon; Louis C Doré; Lauren Diebold; Olivier Bluteau; Vinciane Mabialah; William Vainchenker; Philippe Dessen; Susan Winandy; Thomas Mercher; John D Crispino
Journal:  Blood       Date:  2013-01-18       Impact factor: 22.113

Review 10.  Ikaros fingers on lymphocyte differentiation.

Authors:  Toshimi Yoshida; Katia Georgopoulos
Journal:  Int J Hematol       Date:  2014-08-02       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.